Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts

Radiotherapy and Oncology

Volumn 82, Issue 3, 2007, Pages 301-307

  Nieder, Carsten ^a   Schill, Sabine ^a   Kneschaurek, Peter ^a   Molls, Michael ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac morbidity; IMRT; Lymphoma; Mediastinum; Radiotherapy

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEART INJURY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPHOMA; MEDIASTINUM; PRIORITY JOURNAL; RADIATION DOSE; SECOND CANCER;

BREAST; BREAST NEOPLASMS; ESOPHAGUS; FEMALE; HEART; HUMANS; LUNG; LYMPHOMA; MEDIASTINAL NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK; SPINAL CORD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847374562     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.10.015     Document Type: Article

References (19)

1. Noordijk E.M., Carde P., Dupouy N., et al. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol 24 (2006) 3128-3135
2. Ha C.S., Cabanillas F., Lee M.S., et al. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Int J Radiat Oncol Biol Phys 63 (2005) 188-193
3. Eich H.T., Haverkamp U., Engert A., et al. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma - a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 63 (2005) 860-865
4. Tsang R.W., and Gospodarowicz M.K. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol 23 (2005) 10-17
5. Yahalom J. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). Eur J Haematol 66 (2005) 90-97
6. Chandra A., Guerrero T.M., Liu H.H., et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77 (2005) 247-253
7. Woudstra E., Heijmen B.J., and Storchi P.R. Automated selection of beam orientations and segmented intensity-modulated radiotherapy (IMRT) for treatment of oesophagus tumors. Radiother Oncol 77 (2005) 254-261
8. Goodman K.A., Toner S., Hunt M., et al. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 62 (2005) 198-206
9. Girinsky T., Pichenot C., Beaudre A., et al. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?. Int J Radiat Oncol Biol Phys 64 (2006) 218-226
10. Moser E.C., Noordijk E.M., Carde P., et al. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma 6 (2005) 122-130
11. Koontz B.F., Kirkpatrick J.P., Clough R.W., et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. J Clin Oncol 24 (2006) 605-611
12. Hull M.C., Morris C.G., Pepine C.J., and Mendenhall N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290 (2003) 2831-2837
13. Chronowski G.M., Wilder R.B., Tucker S.L., et al. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 36-43
14. Schwarz M., van der Geer J., van Herk M., et al. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment. Int J Radiat Oncol Biol Phys 65 (2006) 1260-1269
15. Van Leeuwen F.E., Klokman W.J., Stovall M., et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2003) 971-980
16. Travis L.B., Hill D., Dores G.M., et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97 (2005) 1428-1437
17. Prosnitz R.G., Chen Y.H., and Marks L.B. Cardiac toxicity following thoracic radiation. Semin Oncol 32 (2005) S71-S80
18. Hutchings M., Eigtved A.I., and Specht L. FDG-PET in the clinical management of Hodgkin lymphoma. Crit Rev Oncol Hematol 52 (2004) 19-32
19. Grosu A.L., Piert M., Weber W.A., et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181 (2005) 483-499